Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000089

Options or other derivatives

  • Chief Financial Officer acquired 140,807 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jones Cecilia · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-09-26 Grant or award : show line 1 in the form Stock options (right to buy) +118,390 118,390 D
2022-09-26 Grant or award : show line 2 in the form Restricted stock units +22,417 22,417 D
Loading xslF345X03/wf-form4_166439584185254.xml…